Imperative Care
Develops treatments for patients suffering from thromboembolic disease
$100MGrowth
Role not disclosedLP
Longaeva Partners
Activity from announced rounds
Activity in this selectionUnited States · Oct 9, 2026 · Jan 1, 2026
Longaeva Partners is the investment organization named in Imperative Care and Nscale financing histories.
Recorded funding activity
Imperative develops treatments for thromboembolic disease. Nscale supplies AI training and inference infrastructure. Their event records remain separate, and Nscale’s source-versus-structured syndicate discrepancy requires its own participant review.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $100M 1 disclosed · full round size, not this investor’s share